The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis.
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005601:Framycetin / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D007896:Leishmaniasis / Q000188:drug therapy*; D051379:Mice; D009355:Neomycin / Q000627:therapeutic use*; D010303:Paromomycin / Q000627:therapeutic use
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D005601:Framycetin; D007612:Kanamycin; D010303:Paromomycin; D009355:Neomycin